← Back to Clinical Trials
Recruiting NCT07024979

NCT07024979 Music Therapy's Impact on University Students' Social and Mental Health

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07024979
Status Recruiting
Phase —
Sponsor The University of Hong Kong
Condition Depressive Symptoms
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2025-02-10
Primary Completion 2025-12-31

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
Music Therapy Songwriting Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2025-02-10 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

In recent years, university education has become more challenging due to increased academic competition. A rising number of university students globally are currently being diagnosed with mental health problems, and previous research suggests that insufficient social support plays a significant role in the development of mental illnesses, such as symptoms of depression and anxiety. Music Therapy has been widely used in emotional regulation, offering a promising solution for people struggling with anxiety, depression, and social isolation. Research on the neural mechanisms underlying music therapy represents rapidly growing field of study. Hyperscanning is one of the useful neuroscience study methods, which is widely-used for study interbrain synchronization, refers to the simultaneous measurement of brain activity in two or more individuals who are interacting with each other. This study aims to investigate the effectiveness of music therapy intervention in enhancing mental health and social skills of university students with depressed, anxious, and stress symptoms. This current study will adopt a 2-arm randomized controlled design comparing therapeutic songwriting (experimental condition) with non-therapeutic music listening and discussion (control condition). Upon screening for inclusion criteria, baseline data will be collected; and eligible participants will be randomized into either 4 individual music therapy sessions or non-therapeutic music listening and discussion sessions.

Eligibility Criteria

Inclusion Criteria: * (1) adults who aged between 18-40 * (2) without any mental diagnosis * (3) able to speak and read Mandarin, Cantonese, or English * (4) moderate stress or problems in academic activities, problems in interpersonal relationships, or adaptability to college life. * (5) participants DASS-21 score \>= "Moderate" severity on each subscale (Depression \>= 14; Anxiety \>= 10; Stress \>= 19). Exclusion Criteria: * (1) has more than 10 consecutive years professional music training * (2) with chronic illness and taking medication * (3) with prior history of brain trauma or brain surgery * (4) wearing metal piercings or implants.

Contact & Investigator

Central Contact

Wanru Zhao

✉ wanru@connect.hku.hk

📞 (852)59745737

Principal Investigator

Wanru Zhao

PRINCIPAL INVESTIGATOR

The University of Hong Kong

Frequently Asked Questions

Who can join the NCT07024979 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 35 Years, studying Depressive Symptoms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07024979 currently recruiting?

Yes, NCT07024979 is actively recruiting participants. Contact the research team at wanru@connect.hku.hk for enrollment information.

Where is the NCT07024979 trial being conducted?

This trial is being conducted at Hong Kong, Hong Kong.

Who is sponsoring the NCT07024979 clinical trial?

NCT07024979 is sponsored by The University of Hong Kong. The principal investigator is Wanru Zhao at The University of Hong Kong. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology